Skip to main content

Search

Joshua Moses

Joshua

I teach anthropology and environmental studies at Haveford College, just outside of Philly. Currently, I'm holed up in a cabin in the Adirondacks in upstate New York with several family members, including my spouse and 4 year old daughter and 3 dogs. I started working on disasters by accident, when one day in 2001 I was walking to class at NYU and saw the World Trade Center buildings on flames. I have known Kim for a few year and I contacted her to connect with folks around Covid-19 and its imacts.

I'm particularly intersted in issues of communal grief, mourning, and bereavement. Also, I'm interested in the religious response to Covid-19.

pece_annotation_1473995548

tamar.rogoszinski
  1. I first looked up travel to and from Liberia during the Ebola outbreak, since it had been seized. There was a ban, which has since been lifted after, but people coming to and from West Africa are still screened and recommended to visit physicians. As of mid-2015 there wa still a 21 day monitoring period needed. http://www.infectioncontroltoday.com/news/2015/05/cdc-downgrades-travel…'
  2. I was interested if there had been any progress on treatment for Ebola, but found that the main form of treatment is supportive care. Doctors are informed to provide IV fluid and ensure that the patient's immune response and other bodily functions are functioning properly. A vaccine is being worked on but has not gone through a trial to prove safety and effectiveness. https://www.cdc.gov/vhf/ebola/treatment/index.html
  3. I looked further into the vaccine being produced for Ebola. Currently, there is a combined phase 2 and phase 3 trial occurring in Sierra Leone called STRIVE (Sierra Leone Trial to Introduce a Vaccine against Ebola). The study is unblinded, so patients know whether or not they have received the vaccine. The vaccine is a rVSV-ZEBOV, or recombinant Vesicular Stomatitis Virus Zaire ebolavirus vaccine. This vaccine is also being used in phase 2 and phase 3 trials in Guinea and Liberia http://www.cdc.gov/vhf/ebola/strive/qa.html

pece_annotation_1475202196

tamar.rogoszinski

The convention in 1951 was a response to WW2 and the vast amounts of refugees that existed as a result. States involved in the convention and the UN could decide to apply it to refugees not necessarily from WW2, but in 1967, the limits were removed and made it so that it could apply to any refugees, not just those from WW2. It has since been used during major refugee crises in Africa, the Middle East, and Asia.